Taisho Pharmaceutical Co., Ltd. [Head Office: Toshima-ku, Tokyo; President: Shigeru Uehara] (hereinafter referred to as "the Company") hereby announces that sales of "Claritin EX" (Class 2 OTC Drug) from the Company will end at the end of September 2026. While the Company's sales of "Claritin EX" will cease, Bayer Yakuhin, Ltd., the brand's responsible entity, is currently considering future sales policies for "Claritin EX". Details are expected to be announced by Bayer Yakuhin, Ltd. once they are finalized. We express our deepest gratitude to our customers and all stakeholders who have patronized us for many years. ■ "Claritin EX" List Product Name / Packaging Claritin EX / 7 tablets Claritin EX / 14 tablets Claritin EX / 28 tablets Claritin EX / 56 tablets ◇ Brand Site https://brand.taisho.co.jp/claritin/ ◇ Inquiries about products from consumers Customer Service Center TEL: 0120-721-800